Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-15

Clinical Trial Update: Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tamoxifen to anastrozole, alone or with zoledronic acid in breast cancer; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)
  • Tamoxifen (tamoxifen)
  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-03-15